Biography and Research Information
OverviewAI-generated summary
Rajshekar A. Kore's research focuses on understanding molecular mechanisms within cancer progression and developing diagnostic tools. His work investigates the intricate interactions between tumor exosomes and macrophages, specifically examining the role of tumor-associated glycans and scavenger receptor class A in this process. Kore is also developing a blood-based assay designed for the detection of tumor hypoxia, a condition often associated with aggressive cancer growth and resistance to therapy.
His scholarship metrics include an h-index of 15, with 36 total publications and 729 total citations. Kore collaborates with researchers at the University of Arkansas for Medical Sciences, including Ruud P.M. Dings, Robert Griffin, Azemat Jamshidi-Parsian, and Steven R. Post, with whom he has shared publications.
Metrics
- h-index: 1
- Publications: 3
- Citations: 1
Selected Publications
-
Hydrocortisone Use for Septic Shock in Patients With CKD (2026)
-
Abstract 7625: Development of a blood-based tumor hypoxia detection assay (2026)
-
Higher Glycolysis in Circulating Leukocytes in Patients with CKD (2024)
-
Platelets, inflammation, and purinergic receptors in chronic kidney disease (2024)
-
Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024)
-
Authors' Reply: Platelet Count, Platelet Volume and CKD (2024)
-
Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain (2023)
-
Updates on New Therapies for Patients with CKD (2023)
-
Platelet Count and Platelet Volume in Patients with CKD (2023)
-
Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes (2023)
-
Proteomic Analysis of Transcription Factors Involved in the Alteration of Ischemic Mouse Heart as Modulated by MSC Exosomes (2023)
-
Mesenchymal Stem Cell Treatment for Hyperactive Immune Response in Patients with COVID-19 (2022)
-
Author Correction: Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes (2022)
-
The Structural Basis of Effective LOX-1 Inhibition (2022)
-
Proteomic basis of modulation of postischemic fibrosis by MSC exosomes (2021)
Collaboration Network
Top Collaborators
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A
- Abstract 7625: Development of a blood-based tumor hypoxia detection assay
- Abstract 7625: Development of a blood-based tumor hypoxia detection assay
- Abstract 7625: Development of a blood-based tumor hypoxia detection assay
- Abstract 7625: Development of a blood-based tumor hypoxia detection assay
- Abstract 7625: Development of a blood-based tumor hypoxia detection assay
Similar Researchers
Based on overlapping research topics